(19)
(11) EP 4 499 225 A1

(12)

(43) Date of publication:
05.02.2025 Bulletin 2025/06

(21) Application number: 23778704.9

(22) Date of filing: 30.03.2023
(51) International Patent Classification (IPC): 
A61P 25/16(2006.01)
A61K 35/17(2025.01)
A61P 25/28(2006.01)
(52) Cooperative Patent Classification (CPC):
A61P 25/16; A61K 36/06; A61K 36/88; A61K 31/201
(86) International application number:
PCT/IN2023/050315
(87) International publication number:
WO 2023/187838 (05.10.2023 Gazette 2023/40)
(84) Designated Contracting States:
AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC ME MK MT NL NO PL PT RO RS SE SI SK SM TR
Designated Extension States:
BA
Designated Validation States:
KH MA MD TN

(30) Priority: 30.03.2022 IN 202211019288

(71) Applicants:
  • Council of Scientific and Industrial Research, an Indian Registered Body Incorporated under Regn. of Soc. Act (Act XXI of 1860)
    New Delhi, Delhi 110 001 (IN)
  • National Institute of Mental Health and Neurosciences (NIMHANS)
    Bangalore 560029 (IN)

(72) Inventors:
  • B., Padmanabhan
    Karnataka Bangalore 560029 (IN)
  • ASIF, Ali
    Delhi 110007 (IN)
  • DESHMUKH, Prashant
    Karnataka Bangalore 560029 (IN)
  • UNNI, Sruthi
    Karnataka Bangalore 560029 (IN)
  • YEDUKONDALU, Nalli
    Jammu (IN)
  • M M, Srinivas Bharath
    Karnataka Bangalore 560029 (IN)
  • RIYAZ-UL-HASSAN, Syed
    Jammu (IN)
  • AHMED, Wani Zahoor
    Jammu (IN)

(74) Representative: Nederlandsch Octrooibureau 
P.O. Box 29720
2502 LS The Hague
2502 LS The Hague (NL)

   


(54) PHIALOMUSTIN B (1) FOR TREATMENT OF PARKINSON'S DISEASE (PD) AND AMYOTROPHIC LATERAL SCLEROSIS (ALS)